$2.54
-0.09-3.39%
At Close: -
$2.43
-0.11-4.33%
After Hours: Sep 13, 6:42 PM EDT
15 minutes delayed
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for XTL Biopharmaceuticals in recent months.
Browse guidance and forecast on all stocks.